Loss of p16: A Bouncer of the Immunological Surveillance?

Life (Basel). 2021 Apr 2;11(4):309. doi: 10.3390/life11040309.

Abstract

p16INK4A (hereafter called p16) is an important tumor suppressor protein frequently suppressed in human cancer and highly upregulated in many types of senescence. Although its role as a cell cycle regulator is very well delineated, little is known about its other non-cell cycle-related roles. Importantly, recent correlative studies suggest that p16 may be a regulator of tissue immunological surveillance through the transcriptional regulation of different chemokines, interleukins and other factors secreted as part of the senescence-associated secretory phenotype (SASP). Here, we summarize the current evidence supporting the hypothesis that p16 is a regulator of tumor immunity.

Keywords: cell-cycle; chemotherapy resistance; melanoma; pancreatic adenocarcinoma; senescence; senescence-associated secretory phenotype (SASP); tumor infiltration.

Publication types

  • Review